Inovio Pharmaceuticals Inc (INO)

[Everywhereman]

Is the HIV Data priced in???
The HIV data will be peer reviewed. Depending on the peer review part of the report can go many different ways. The trial data can be good ( I am petty sure it is) but if the reviewers do not like the way the trial was conducted, that can bring a negative spin on the whole thing. If the data is good and the peers like the way the trial was constructed and run and agree with the conclusions, it will bring added credibility. This will bring more people into the stock. So, I think good data is prob half in the price right now, but good peer data is not even in most people's thought processes yet. If the review process is good it should bring in good pr and more eyes. I have no doubt that Joseph has set this up so that the extra peer review process makes the data more attractive to the FDA as well as investors. If we are VERY fortunate, we may get fast track consideration for the vaccine.
People here act like INO is a typical Biotech run typical people, it is not. Joseph Kim is one of the smartest people in the business, and is most likely THE smartest. Few CEOs invented their technology, or were deeply involved in the development of it. On top of the scientists that run companies, few indeed have a Wharton MBA. Joseph has all of these qualities and more. Not to mention his undergrad form MIT. Inovio unlike most early to mid stage companies had a manufacturing plant in The Wooddlands TX. They have been successfully manufacturing trial drugs for companies for over 5 years. This is far from the normal in small cap companies and only adds to the value more as people learn the story.